uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Share-based Compensation (2015 - 2026)

uniQure (QURE) posted quarterly Share-based Compensation of $40.8 million for Q2 2026, up 407660.0% year-over-year from N/an in Q2 2025, and up 701.1% quarter-over-quarter from $5.1 million in Q1 2026.

Analysis

uniQure (QURE) Share-based Compensation (2015 - 2026) Analysis & Trends

uniQure's Share-based Compensation history runs 11 years deep, the most recent figure standing at $40.8 million for Q2 2026.

  • In Q2 2026, Share-based Compensation rose 407660.0% year-over-year to $40.8 million; the TTM figure through Jun 2026 stood at $40.8 million (up 344.81% YoY), while the FY2025 annual figure was $32.3 million, up 45.03% from the prior year.
  • Share-based Compensation for Q2 2026 stood at $40.8 million, up from $5.1 million in the prior quarter.
  • The five-year high for Share-based Compensation was $40.8 million in Q2 2026, with the low at -$2000.0 in Q3 2024.
  • The 5-year median for Share-based Compensation is $7.0 million (2022), against an average of $7.6 million.
  • The sharpest annual moves came in 2024 and 2026: Share-based Compensation plunged 100.02% in 2024, then soared 407660.0% in 2026.
  • uniQure's Share-based Compensation stood at $11.9 million in 2022, then sank by 40.9% to $7.0 million in 2023, then plunged by 32.55% to $4.7 million in 2024, then slipped by 1.81% to $4.7 million in 2025, then surged by 774.46% to $40.8 million in 2026.
  • Business Quant data shows QURE's Share-based Compensation at $40.8 million in Q2 2026, $5.1 million in Q1 2026, and $4.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 40.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.78 Mn
Mar 31, 2026 5.27 Mn
Dec 31, 2025 4.66 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 86,712.00
Mar 31, 2025 4.41 Mn
Dec 31, 2024 4.75 Mn
Sep 30, 2024 86,712.00
Jun 30, 2024 86,712.00
Mar 31, 2024 7.19 Mn
Dec 31, 2023 7.04 Mn
Sep 30, 2023 11.10 Mn
Jun 30, 2023 8.89 Mn
Mar 31, 2023 8.06 Mn
Dec 31, 2022 11.91 Mn
Sep 30, 2022 7.61 Mn
Jun 30, 2022 7.81 Mn
Mar 31, 2022 6.87 Mn
Dec 31, 2021 6.89 Mn
Sep 30, 2021 5.96 Mn